Vanin 1: Its Physiological Function and Role in Diseases

被引:87
作者
Bartucci, Roberta [1 ,2 ,3 ]
Salvati, Anna [1 ]
Olinga, Peter [2 ]
Boersma, Ykelien L. [3 ]
机构
[1] Univ Groningen, Groningen Res Inst Pharm, Div Pharmacokinet Toxicol & Targeting, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen, Groningen Res Inst Pharm, Div Pharmaceut Technol & Biopharm, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands
[3] Univ Groningen, Groningen Res Inst Pharm, Div Chem & Pharmaceut Biol, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands
关键词
vanin; 1; oxidative stress; PPAR-alpha; PPAR-gamma; urinary biomarker; pro-inflammatory role; protective role; NONALCOHOLIC FATTY LIVER; GENE-EXPRESSION; PANTOTHENIC-ACID; NATURAL-HISTORY; COENZYME-A; PPAR-ALPHA; MOUSE; PANTETHEINASE; CYSTEAMINE; PROTEIN;
D O I
10.3390/ijms20163891
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme vascular non-inflammatory molecule-1 (vanin 1) is highly expressed at gene and protein level in many organs, such as the liver, intestine, and kidney. Its major function is related to its pantetheinase activity; vanin 1 breaks down pantetheine in cysteamine and pantothenic acid, a precursor of coenzyme A. Indeed, its physiological role seems strictly related to coenzyme A metabolism, lipid metabolism, and energy production. In recent years, many studies have elucidated the role of vanin 1 under physiological conditions in relation to oxidative stress and inflammation. Vanin's enzymatic activity was found to be of key importance in certain diseases, either for its protective effect or as a sensitizer, depending on the diseased organ. In this review, we discuss the role of vanin 1 in the liver, kidney, intestine, and lung under physiological as well as pathophysiological conditions. Thus, we provide a more complete understanding and overview of its complex function and contribution to some specific pathologies.
引用
收藏
页数:15
相关论文
共 91 条
[1]   Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing [J].
AurrandLions, M ;
Galland, F ;
Bazin, H ;
Zakharyev, VM ;
Imhof, BA ;
Naquet, P .
IMMUNITY, 1996, 5 (05) :391-405
[2]  
Bennett MR, 2017, BIOMARKERS OF KIDNEY DISEASE, 2ND EDITION, P1, DOI 10.1016/B978-0-12-803014-1.00001-7
[3]   Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress [J].
Berruyer, C ;
Martin, FM ;
Castellano, R ;
Macone, A ;
Malergue, F ;
Garrido-Urbani, S ;
Millet, V ;
Imbert, J ;
Duprè, S ;
Pitari, G ;
Naquet, P ;
Galland, F .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (16) :7214-7224
[4]   Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor γ activity [J].
Berruyer, Carole ;
Pouyet, Laurent ;
Millet, Virginie ;
Martin, Florent M. ;
LeGoffic, Aude ;
Canonici, Alexandra ;
Garcia, Stephane ;
Bagnis, Claude ;
Naquet, Philippe ;
Galland, Franck .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (13) :2817-2827
[5]   Cysteamine: an old drug with new potential [J].
Besouw, Martine ;
Masereeuw, Rosalinde ;
van den Heuvel, Lambert ;
Levtchenko, Elena .
DRUG DISCOVERY TODAY, 2013, 18 (15-16) :785-792
[6]   The structure of vanin 1: a key enzyme linking metabolic disease and inflammation [J].
Boersma, Ykelien L. ;
Newman, Janet ;
Adams, Timothy E. ;
Cowieson, Nathan ;
Krippner, Guy ;
Bozaoglu, Kiymet ;
Peat, Thomas S. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2014, 70 :3320-3329
[7]   Acute renal failure. I. Relative importance of proximal vs. distal tubular injury [J].
Bonventre, JV ;
Brezis, M ;
Siegel, N ;
Rosen, S ;
Portilla, D ;
Venkatachalam, M ;
Lieberthal, W ;
Nigam, SK .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 275 (05) :F623-F631
[8]   Regression of Liver Fibrosis [J].
Campana, Lara ;
Iredale, John P. .
SEMINARS IN LIVER DISEASE, 2017, 37 (01) :1-10
[9]  
CAVALLINI D, 1968, Febs Letters, V1, P119, DOI 10.1016/0014-5793(68)80036-5
[10]  
Cayón A, 2008, REV ESP ENFERM DIG, V100, P212, DOI 10.4321/s1130-01082008000400004